B
Bolt Biotherapeutics, Inc.
BOLTHealth Care· Cambridge, MA, US
LAYOFFS TRACKED
1
LAST EVENT
Jul 15, 2024
MARKET CAP
$7.55M
as of Aug 26, 2026
EMPLOYEES
25
Bolt Biotherapeutics, Inc. is a clinical-stage immuno-oncology company developing tumor-directed immunotherapeutics called Immune-Stimulating Antibody Conjugates (ISACs) to activate innate and adaptive immunity in the tumor microenvironment. The company focuses on targeted activation of immune pathways to treat solid tumors and is advancing multiple clinical and preclinical programs.
Layoff timeline
1 EVENTJul 15, 2024WARN notice
Layoff at Bolt Biotherapeutics, Inc. · ~38 roles
Chesapeake Drive Redwood City, CA
Stories from here
No one has shared a story from Bolt Biotherapeutics yet. Went through a layoff here? Your experience helps others feel less alone.
Share your story →Get alerts for Bolt Biotherapeutics
We'll email you the moment a new layoff is reported here.